The emerging approach of this peptide represents a major breakthrough in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide975471.blogrenanda.com/48973730/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment